Long-Term Visual Outcomes And Quality Of Life After Smile In Myopia
Published 2022
- 40th Congress of the ESCRS
Reference: FPM11.11
| Type: Free paper
| DOI:
10.82333/a26h-jp69
Authors:
Aarush Deora* 1
, Jeewan Titiyal 1
, Manpreet Kaur 1
, Sridevi Nair 1
1Ophthalmology,Dr. R.P Centre for Ophthalmic Sciences, AIIMS,New Delhi,India
Purpose
The evaluate the long-term visual outcomes and patient satisfaction after Small Incision lenticule extraction (SMILE) in myopia.
Setting
Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi.
Methods
Ambispective study included 115 eyes of 58 patients who underwent SMILE for correction of myopia and completed 5 years follow-up. Primary outcomes measures were uncorrected distance visual acuity (UDVA) and refractive predictability at 5 years. Secondary outcomes measures were quality of life ascertained using Quality of Life Impact of Refractive Correction (QIRC) questionnaire and safety.
Results
The preoperative mean refractive spherical equivalent (MRSE) was 4.89±1.91 D. At 5 years follow-up, mean UDVA was 0.06 ± 0.13 and 82% of eyes were within 0.5D of intended correction. There was a mean regression of -0.18 ± 0.41 D over 5 years. Significant improvement was observed in the total QIRC score (53.09 ± 3.99 vs 41.58 ± 3.59, P < 0.001). No eyes lost 2 or more lines of corrected distance visual acuity. Incidence of retreatment was 2.6%. A significantly better efficacy (83.9% vs 57.1%, p value=0.003) and refractive predictability (87% vs 64%; p=0.006) was observed in the low-moderate myopic eyes (n=83) as compared to high myopic eyes (n=32).
Conclusions
SMILE is a safe and efficacious modality for treatment of myopia that provides excellent patient satisfaction and quality of life over long-term follow-up. Efficacy and predictability were better in the low-moderate myopic eyes as compared to high myopic eyes.